Therefore, we highlight pharmacological approaches for MASLD that are weight-neutral or associated with weight reduction or weight gain (mostly an increase in subcutaneous adipose tissue) (see Text box, Summary of pharmacological treatment of MASH in people with type 2 diabetes)
Their absence from the label means incidence is unknown, not that the symptom cannot occur
Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, Haussinger D: Functional significance of cell volume regulatory mechanisms
Safety, Side Effects, and When to Pause and Reassess L-carnitine is generally considered safe for dogs when used appropriately, with relatively few reported adverse effects (Tanprasertsuk J, 2022)
Identification of sequence polymorphisms in the mitochondrial cytochrome c oxidase genes as risk factors for hepatocellular carcinoma